Compare UTHR & CPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | CPRT |
|---|---|---|
| Founded | 1996 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 27.0B |
| IPO Year | 1999 | 1996 |
| Metric | UTHR | CPRT |
|---|---|---|
| Price | $487.75 | $33.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 5 |
| Target Price | ★ $567.57 | $44.40 |
| AVG Volume (30 Days) | 467.9K | ★ 9.3M |
| Earning Date | 05-06-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.07 | ★ 13.57 |
| EPS | ★ 13.07 | 1.20 |
| Revenue | $1,483,300,000.00 | ★ $1,805,695,000.00 |
| Revenue This Year | $6.39 | $1.23 |
| Revenue Next Year | $14.18 | $4.68 |
| P/E Ratio | $37.66 | ★ $26.80 |
| Revenue Growth | ★ 2.38 | N/A |
| 52 Week Low | $375.61 | $26.81 |
| 52 Week High | $609.35 | $48.88 |
| Indicator | UTHR | CPRT |
|---|---|---|
| Relative Strength Index (RSI) | 35.32 | 62.40 |
| Support Level | $464.92 | $32.52 |
| Resistance Level | $489.48 | $34.28 |
| Average True Range (ATR) | 13.13 | 1.09 |
| MACD | -1.88 | -0.05 |
| Stochastic Oscillator | 21.13 | 68.46 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
Based in Dallas, Copart operates a global online salvage vehicle auction with operations in 11 countries across North America, Europe, and the Middle East, facilitating over 4 million transactions annually. The company utilizes its virtual bidding platform, VB3, to connect vehicle sellers with over 750,000 registered buyers around the world. Buyers primarily consist of vehicle dismantlers, rebuilders, individuals and used vehicle retailers. About 80% of Copart's vehicle volume is supplied by auto insurance companies holding vehicles deemed a total loss. Copart also offers services such as vehicle transportation, storage, title transfer, and salvage value estimation. The company primarily operates on a consignment basis and collects fees based on the vehicle's final selling price.